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Abstract At present there are no known procedures
for preventing or treating infectious diseases of corals.
Toward this end, the use of phage therapy has been
investigated. Lytic bacteriophages (phages) were iso-
lated for two bacterial pathogens that are responsible
for coral diseases, Vibrio coralliilyticus, which is the
causative agent of bleaching and tissue lysis of Pocillo-
pora damicornis, and Thalosomonas loyaeana, which
causes the white plague-like disease of Favia favus. By
using these phages in controlled aquaria experiments,
it was demonstrated that each of these diseases could
be controlled by the pathogen-speciWc phage. The data
indicate that initially the phages bind to the pathogen
in seawater and are then brought to the coral surface
where they multiply and lyse the pathogen. The phages
remained associated with the coral and could prevent
subsequent infections. These data suggest that phage
therapy has the potential to control the spread of infec-
tious coral diseases.
Keywords Phage therapy · Bacteriophage · Coral 
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Introduction
Infectious diseases of corals cause serious damage to
coral reefs throughout the world (Green and Bruckner
2000; Harvell et al. 2002). In several cases, the microor-
ganism responsible for the disease has been identiWed
(Kushmaro et al. 1996; Richardson 1998; Ritchie et al.
2001; Rosenberg and Ben-Haim 2002). It is now clear
that environmental factors, especially increased seawa-
ter temperature and pollution, contribute to disease
formation (Rosenberg and Ben-Haim 2002; Bruno
et al. 2003; Kerri et al. 2004; Kuntz et al. 2005; Kline
et al. 2006), and every eVort should be made to avoid
these deleterious factors. However, it is equally impor-
tant to develop therapeutic methods for preventing
and curing infectious diseases of corals. Two widely
used methods for controlling human diseases, immuni-
zation and antibiotic treatment, are not applicable to
coral diseases because corals have no adaptive immune
system (Nair et al. 2005) and introduction of antibiotics
in an open system like a coral reef is not practical. An
alternative therapeutic method is phage therapy.
The use of bacterial viruses (bacteriophages, or
phages for short) for the treatment of human disease
has had a long and rocky history (Lederberg 1996;
Chanishvili et al. 2001; Sulakveldize et al. 2001). How-
ever, many of the intrinsic diYculties of treating
humans by phage therapy are irrelevant to corals, such
as uptake of the phages by the spleen, and destruction
by opsonization and neutralizing antibodies. The major
advantages of phage therapy of coral diseases are host
speciWcity, self replication and environmental safety.
The phage only attacks and destroys the speciWc patho-
gen, leaving the remaining beneWcial microorganisms
untouched. The phage multiplies rapidly at the
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titer for more eVective control of the pathogen. When
the pathogen concentration decreases suYciently, the
phage will also decline (Weld et al. 2004). Phage ther-
apy has been used to protect Wsh against experimen-
tally-induced bacterial infections in aquaculture (Nakai
and Park 2002).
In this study, the application of phage therapy was
tested with two coral diseases: tissue lysis of Pocillo-
pora damicornis by Vibrio coralliilyticus (Ben-Haim
and Rosenberg 2002; Ben-Haim et al. 2003a, b) and the
white plague-like disease of Eilat (Gulf of Aqaba, Red
Sea) corals caused by Thalosomonas loyaeana (Barash
et al. 2005; Thompson et al. 2006). V. coralliilyticus is a
novel species that has been recently isolated from dis-
eased corals and other marine invertebrates in the Red
Sea, Indian Ocean, Atlantic Ocean and Great Barrier
Reef (Ben-Haim and Rosenberg 2002; Bourne and
Munn 2005). At 25°C, V. coralliilyticus causes bleach-
ing of P. damicornis in 20–25 days, whereas at 27–30°C
the pathogen causes tissue lysis and death in 10–
15 days (Ben-Haim et al. 2003 a, b). The white plague-
like disease is currently the most serious disease on the
Eilat coral reef. T. loyaeana, is the causative agent of
this disease on several large corals, including Favia
favus, Platygyra sp. and Goniastrea sp. Approximately
10% of the colonies of each of these genera show pro-
gressive signs of the disease or are dead as a result of
the infection. In the Weld, the disease spreads within
the colony at a maximum recorded rate of 11 mm per
day (Barash et al. 2005).
Materials and methods
Bacteria, media and growth conditions
Strains were routinely cultivated in liquid MBT
medium (1.8% Marine Broth, 0.9% NaCl and 0.5%
Difco Tryptone) at 30°C. Liquid cultures were pre-
pared in 125 ml Xasks containing 10 ml MBT, inocu-
lated with one colony, and incubated at 30°C with
shaking (160 rpm) for 48 h. The strains were main-
tained on MB Agar (1.8% Marine Broth, 0.9% NaCl
and 1.8% Bacto Agar). Stock cultures were stored in
15% glycerol at ¡70°C.
Bacteriophage isolation and preparation of high titer 
phage stocks
Seawater was collected from the Red Sea near the
Intrauniversity station in Eilat, Israel. Aliquots of
500 ml were Wltered through 0.22 m membrane Wlters
(Millipore). The Wltrates were then concentrated 100-
fold (TFF-Tangential Flow Filtration) and either
plated directly or were used in enrichment cultures.
Plaques were obtained over lawns of the diVerent
hosts: V. coralliilyticus or T. loyaeana by the soft agar
overlay technique (Adams 1959), using 0.6% agar and
incubating at 30°C for 24 h. Several rounds of plaque
puriWcations were performed to ensure a pure phage
stock. High titer stocks were made by infecting fresh
culture of bacteria (A600 = 0.6) with approximately
1 £ 106 pfu ml¡1. After about 2 h the culture became
clear and was centrifuged to remove any remaining
bacteria and large debris.
Electron microscopy
Phages were classiWed on the basis of morphology
determined by electron microscopy. High titer bacte-
riophage lysates were negatively stained with 1% ura-
nyl acetate and examined with a JEOL 840A electron
microscope at 80 kV.
Collection and maintenance of corals
Corals for laboratory infection experiments were col-
lected by SCUBA diving oV Eilat in the Gulf of Aqaba,
Red Sea, from depths of 2–6 m. In the case of P. dami-
cornis, ca. 2 cm2 pieces were taken from the same colony.
With F. favus, each piece was a separate small colony (ca.
3 cm diameter). The corals were then allowed to recover
and regenerate in 3–10 l, glass-covered aerated aquaria at
the same seawater temperature (21–26°C) at which they
were collected. After tissue recovery the corals were
slowly acclimated to the experimental temperature by
increasing the temperature no more than 0.5°C per day.
The corals were maintained at the experimental temper-
ature for a further 7–14 days prior to the experiment. If
any fragment failed to heal (completely cover over the
broken edges with new tissue, and exhibit dark pigmen-
tation), it was not used in the experiments. The corals
were maintained in freshly prepared artiWcial seawater
(ASW, Instant Ocean, USA) adjusted to salinity of 35–
37 ppt. Water was replaced every 3–6 days. The aquaria
were aerated and illuminated with Xuorescent lamps
(Sylvania, Aquastar 10,000 K) by using a regimen of 12 h
light:12 h of darkness.
Phage adsorption experiments
Overnight cultures of V. corallilyticus and T. loyaeana
were transferred to fresh MBT medium and allowed to
grow until they reached A600 = 0.4 (exponential phase).
The cultures were then centrifuged, and the pellets123
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ASW. To prevent multiple adsorptions, the adsorption
experiments were performed with Wnal concentrations
of 5 £ 106 and 5 £ 105 ml¡1 of bacteria and phages,
respectively. Samples were withdrawn at timed inter-
vals and diluted 100-fold to prevent further adsorption.
The suspension was then centrifuged for 2 min at
8,000g to remove adsorbed phages, and the superna-
tant Xuid (containing free virons) was assayed for
phage by the soft agar overlay technique. One-step
growth curves for each phage was performed as
described in Adams (1959).
Phage therapy of the white-plague-like disease 
of F. favus
Healthy F. favus and corals showing signs of the white
plague-like disease (ca. 3 cm diameter) were placed in
separate aquaria and maintained as described above at
25°C. After 48 h, 300 ml of water from the aquarium
with the diseased coral and 300 ml of artiWcial seawater
were placed in each of nine aquaria. A single healthy
coral was then placed in each aquarium. Six aquaria
were inoculated with phage BA3 (three received
104 pfu ml¡1 and three received 106 pfu ml¡1). The
other three aquaria served as no phage controls.
Protection of the coral P. damicornis against infection 
by V. coralliilyticus with phage YB2
Coral fragments were placed in 2.5 l aquaria containing
2 l of freshly prepared artiWcial seawater (4 or 5 corals
per aquarium). All four aquaria were then infected
with a 48 h culture of V. coralliilyticus at a Wnal concen-
tration of 105 bacteria per ml. Two aquaria containing a
total of nine corals served as the no-phage controls.
The other two aquaria containing a total of nine corals
were inoculated with phage YB2 to reach 103 ml¡1.
Seawater in the aquaria was replaced every 7 days by
removing the corals, draining and rinsing the aquaria,
and adding back the rinsed corals to fresh seawater.
Determination of phage genome size
Bacteriophage preparations (at least 109 pfu ml¡1)
were treated with DNase I and RNase A at 37°C for
15 min to remove contaminating nucleic acids, then
precipitated by 20% PEG (containing 2 M NaCl), lysed
by addition of EDTA (Wnal concentration 20 mM) and
SDS (Wnal concentration 0.5%), followed by incuba-
tion at 68°C for 5 min. The nucleic acids were puriWed
using a phenol, phenol/chloroform, chloroform extrac-
tion, and precipitated with ethanol (Sambrook et al.
1989). The DNA of phage YB2 was fragmented by the
EcoRI and PstI. The DNA of phage BA3 was frag-
mented by the following enzymes: BamHI, HindIII,
EcoRV and EcoRI . All restriction enzymes used were
products of Fermentas Inc., Hanover, MD, USA.
Results
Isolation and characterization of phages
Figure 1 presents photographs and electron micro-
graphs of healthy and diseased corals, bacterial patho-
gens and phages used in this study. The natural
concentrations of phages in the seawater surrounding
the corals that formed plaques on V. coralliilyticus and
T. loyaeana were 5 and 1 per ml, respectively. One dis-
tinct phage for each bacterial pathogen was obtained
after several rounds of plaque puriWcation. Phage YB2
(obtained after enrichment) formed 1.5 mm clear
plaques on V. coralliilyticus. It is a double stranded
DNA phage containing 11 Kbp of circular DNA
(Fig. 2). The uncut DNA (Fig. 2, lane 4) shows the typi-
cal three forms of circular DNA, and a single cut (Fig. 2,
lane 3) yielded the single linear form. One-step growth
curves of phage YB2 on V. coralliilyticus yielded a burst
size of 100 in 80 min at 30°C. Phage BA3 (obtained by
direct plating), which formed 2 mm clear plaques on T.
loyaeana, is a double stranded DNA phage containing
15 Kbp of linear DNA (Fig. 3). One-step growth curves
of phage BA3 on T. loyaeana yielded a burst size of 150
in 120 min at 30°C. Based on their structural morpho-
logies as observed by electron microscopy, phages YB2
(Fig. 1f) and BA3 (Fig. 1h) were classiWed as belonging
to the Corticoviridae (chloroform sensitive) and Podo-
viridae groups, respectively. Both phage YB2 and BA3
are highly speciWc for their respective hosts. Neither
forms plaques on a variety of other marine bacteria
tested. In addition, each phage only attacks its speciWc
host and not other strains of the same species.
Adsorption of phages to bacteria
For phages to be eVective in preventing bacterial infec-
tions of corals, the phage must be able to adhere to the
pathogen in unsupplemented seawater. As summarized
in Figs. 4 and 5, both phages YB2 and BA3 adhered to
their hosts in seawater, albeit at a slower rate than in
MBT medium. Approximately 60% of the input phage
YB2 was bound to V. coralliilyticus in 90 min in ASW,
whereas 90% was bound in 10 min in MBT medium.
Adhesion of phage BA3 to T. loyaeana was only slightly
slower in ASW than in MBT medium. In both cases,123
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hosts in seawater, phages YB2 and BA3 did not multi-
ply or lyse the bacteria, but when transferred to nutrient
rich MBT medium, the bound phages multiplied rapidly
and lysed the bacteria (data not presented).
Protection of P. damicornis against infection 
by V. coralliilyticus by phage YB2
Phage YB2 protected the coral P. damicornis against
infection by V. coralliilyticus (Fig. 6). In each of the
aquaria that did not receive phage, all nine corals began
to lyse after 14 days and were completely devoid of tissue
after 17 days. In the aquaria that contained 103 phages
per ml, all corals remained healthy for at least 2 months.
In a separate experiment, corals that were inoculated
Fig. 1 Corals, bacterial pathogens and bacteriophages used in
this study. a Healthy and b partially lyzed Pocillopora damicornis
(bars 0.5 cm), c healthy and d partially lyzed Favia favus (bars
2 cm). Negatively stained electron micrographs of e Vibrio coral-
liilyticus (bar 0.2 m), f phage YB2 (bar 50 nm), g a thin section
of Thalassomonas loyaeana (bar 0.1 m) and h phage BA3 (bar
50 nm)
Fig. 2 Agarose gel (1%) electrophoresis of bacteriophage YB2
DNA digested with restriction enzymes. Lane 1 100 bp ladder;
lane 2 digestion with EcoRI; lane 3 digestion with PstI; lane 4 non-
digested phage DNA; lane 5 1 Kbp ladder








1 Fig. 3 Agarose gel (1%) electrophoresis of bacteriophage BA3
DNA digested with restriction enzymes. Lane 1, 1 Kbp ladder;
lane 2 digestion with EcoRI; lane 3 digestion with EcoRV; lane 4
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healthy for 33 days, were re-inoculated with the patho-
gen. These corals remained healthy for an additional
month (Fig. 7). Since the phages were only added at the
beginning of the experiment and the water was replaced
weekly, it follows that suYcient phage remained associ-
ated with the coral tissue for at least 1 month to protect
against the second infection. The death of the corals after
27 days (Fig. 7) was probably not the result of infection
with V. coralliilyticus because the pathogen could not be
isolated from these diseased corals.
Protection of F. favus against infection by T. loyaeana 
by phage BA3
The most rapid and reproducible technique for trans-
mitting the white plague-like disease in the laboratory
is to place a healthy coral in water that came from an
aquarium containing a diseased coral (Fig. 8). In the
absence of added phage, all the corals began to show
tissue lysis in 2 days and were dead in 4 days. The cor-
als that were treated with phage remained alive with no
tissue loss for at least 21 days. The only diVerence
between them and healthy non-infected corals was that
the phage-protected corals secreted more mucus than
healthy control corals for the Wrst 3 days after infec-
tion. Both 104 and 106 ml¡1 phages showed the same
inhibition of infection.
During the phage therapy experiment, the concen-
tration of phage BA3 in the aquarium water increased
more than 100-fold during the Wrst 2 h and remained
high throughout the experiment (Fig. 9). After 7 days,
a coral was removed from the aquarium, rinsed and
Fig. 4 Adsorption kinetics of phage YB2 to Vibrio coralliilyticus
in MBT medium (open bars) and in seawater (closed bars). Data



















Fig. 5 Adsorption kinetics of phage BA3 to Thalassomonas loy-
aeana in MBT medium (open bars) and in seawater (closed bars).



















Fig. 6 Protection of the coral Pocillopora damicornis against
infection by Vibrio coralliilyticus with phageYB2. Coral frag-
ments at 28°C were infected with Vibrio coralliilyticus at a Wnal
concentration of 105 ml¡1. Nine corals were inoculated with
103 pfu ml¡1 of phage YB2 (Wlled triangle), and nine corals served
as no phage controls (Wlled square). Data are presented as the
mean § SE
100




















Fig. 7 Protection of phage-treated corals, against a second infec-
tion of Vibrio Coralliilyticus. Corals that looked healthy (for
33 days) in the Phage therapy experiment (Fig. 6) were reinfected
with 105 cfu ml¡1 (Wlled triangle). Fresh corals infected with V. co-
ralliilyticus served as no phage controls (Wlled square). Data are
presented as the mean § SE. In the case of the previously treated























12 Coral Reefs (2007) 26:7–13then crushed in sterile seawater. The titer of phage
BA3 was 7 £ 106 pfu cm¡2, indicating that phage
remained closely associated with the coral tissue.
Discussion
The data presented here demonstrate in two coral
model systems that inoculation of speciWc phages at the
same time as the bacterial pathogens inhibits infection
in aquaria. Since the rate of phage adsorption to its
host was relatively rapid (minutes) compared to bacte-
rial adhesion to the coral (hours), it is reasonable to
assume that the phage was carried to the coral while
bound to the bacterial pathogen. Once the pathogen
reaches the nutritionally rich coral mucus, it begins to
metabolize, allowing for phage multiplication and
resulting bacterial lysis. This concept is supported by
the observation that there was more than 100-fold
increase in phage BA3 during the Wrst 2 h. The titer of
phage associated with coral tissue remained high for
several weeks. This important Wnding can explain (1)
how the phage titer in the water was maintained even
after the water in the aquarium was replaced—by
release of phage from the coral, and (2) how corals
treated with phage and pathogen at day one showed
increased resistance to a second bacterial infection
after 33 days (Fig. 7).
Because of the high degree of host speciWcity, phage
therapy provides an indirect but powerful tool to dem-
onstrate that a particular microorganism is responsible
for a speciWc disease. This is particularly relevant to the
white plague-like disease, because it has not been pos-
sible to reproducibly isolate T. loyaeana from diseased
corals showing signs of the disease (Barash et al. 2005).
The diYculty of isolating T. loyaeana may be due to
the large and diverse number of bacteria associated
with corals (Rohwer et al. 2001, 2002; Koren and
Rosenberg 2006), the lack of a speciWc medium for iso-
lating the bacterium and/or that T. loyaeana may be in
a viable-but-not-culturable (VBNC) state (Colwell
et al. 1985). The data showing that the T. loyaeana-spe-
ciWc phage BA3 blocks the infection and that the phage
multiplied on water taken from a diseased coral, dem-
onstrate that T. loyaeana must have been present on
the diseased coral and is responsible for transmitting
the disease. Based on the known phage burst size, the
presence of 108 pfu ml¡1 2 h after infection (Fig. 9)
indicates that the water taken from the aquarium that
contained a diseased coral (day 0) must have had a
concentration of T. loyaeana >105 ml¡1. Thus, together
with data previously published (Barash et al. 2005), all
of Koch’s postulates have now been satisWed, and it can
be concluded that T. loyaeana is the causative agent of
the white plague-like disease on the Eilat coral reef.
Before applying phage therapy to coral diseases in
an open system, such as a coral reef, three problems
have to be addressed: the most appropriate time to add
the phage, possible development of phage resistance
by the pathogen and obtaining enough phage for a Weld
trial. At present, we do not know the outcome of the
bacterial infections when the phages are added before
or after the bacteria. This needs to be studied. If phage
resistance becomes a problem, it may be necessary to
use a “cocktail” of phages (O’Flynn et al. 2004). The
frequency of mutation of two or more phages is
extremely low. Regarding the number of phages
needed for a Weld trial, let us assume that 103 phages
Fig. 8 Protection of the Favia favus against infection by Thalas-
somonas loyaeana with phage BA3. Nine healthy pieces of F. fa-
vus were placed in separate aquaria containing water that was
taken from an aquarium that contained diseased F. favus. Six
aquaria were inoculated with phage BA3 (Wlled triangle) and
three served as no phage controls (Wlled square). Data are pre-






















Fig. 9 Concentrations of phage BA3 in the aquarium water dur-
ing phage therapy. Samples of water from the experiment de-
scribed in Fig. 8 were titered for phage by the soft agar overlay
technique. After 4, 9 and 13 days (arrows) the water was replaced
with fresh seawater. Initial concentrations of phage were
104 pfu ml¡1 (closed bars) and 106 pfu ml¡1 (open bars). Data are













Coral Reefs (2007) 26:7–13 13ml¡1 will prevent the spread of the disease. (This value
is 1,000 times higher than their natural abundance in
Eilat seawater). A titer of 1011 phages per ml can be
reached in a fermentor. Thus, a 100-l laboratory fer-
mentor will provide 1016 phages, enough to treat 106 m2
of a coral reef to a depth of 10 m. A commercial fer-
mentor (e.g., 100 m3) would probably have to be used
to prepare enough phage for treating large reef areas
(e.g., 1,000 km2). Phage therapy of coral diseases
appears to be achievable.
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